“…Development of 188 W/ 188 Re generators using low specific activity 188 W produced from a moderate flux reactor amenable for routine clinical use is the cornerstone for the survival and strength of 188 Re radiopharmacy. With a view to achieve this objective, several alternate sorbents such as hydroxyapatite, the hydrous oxides of zirconium, titanium, manganese, tin(IV), and cerium, silica gel, the AG 1-X12 and AG 50 W-X12 ion-exchange resins, and activated charcoal, several sorbents with higher capacity for W such as gel–metal oxide composites, synthetic alumina, polymeric titanium oxychloride, and polymeric zirconium compound (PZC) have been studied to determine their suitability for the preparation of 188 W/ 188 Re generators. − Despite many impressive advances, the promise of developing 188 W/ 188 Re generators using low specific activity 188 W for routine clinical use remains elusive. Probably, the electrochemical approach is the only alternative to develop clinical scale 188 W/ 188 Re generators using medium to low specific activity 188 W, which can be produced in medium-flux reactors …”